Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Inserm · Hôpital Beaujon · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,774
total citations
- FWCI
- 77.65
- Percentile
- 100%
- References
- 38
Citations per year
Authors
15- PMPatrick MarcellinCorresponding
Inserm, Hôpital Beaujon
- EGEdward Gane
Auckland City Hospital
- MBMarı́a Buti
Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- NHNezam H. Afdhal
Beth Israel Deaconess Medical Center
- WSWilliam Sievert
Monash Medical Centre, Monash University
Topics & keywords
Topics
Keywords
- Medicine
- Cirrhosis
- Internal medicine
- Gastroenterology
- HBeAg
- Fibrosis
- Adverse effect
- Liver biopsy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.